Concepedia

Publication | Closed Access

Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

DOI

106

Citations

32

References

2014

Year

Annagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, Alberta Cappelli, Alessandro Granito, Alessandro Cucchetti, Sara Marinelli, Cinzia Pettinato, Virginia Erroi, Silvia Fiumana,
Liver International

Abstract

In cirrhotic patients with intermediate-advanced or not-otherwise-treatable HCC, sorafenib and TARE provide similar survivals. Down-staging allowing liver transplantation only occurred after TARE.

References

YearCitations

Page 1